SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-016145
Filing Date
2017-03-13
Accepted
2017-03-13 17:07:52
Documents
8
Period of Report
2017-03-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-8213_18k.htm 8-K 39896
2 EX-4.1 a17-8213_1ex4d1.htm EX-4.1 870454
3 GRAPHIC g82131kg13i001.jpg GRAPHIC 2196
4 GRAPHIC g82131kg13i002.jpg GRAPHIC 2663
5 GRAPHIC g82131kg13i003.jpg GRAPHIC 2605
6 GRAPHIC g82131kg13i004.jpg GRAPHIC 2917
7 GRAPHIC g82131kg15i001.jpg GRAPHIC 2382
8 GRAPHIC g82131kg15i002.jpg GRAPHIC 3770
  Complete submission text file 0001104659-17-016145.txt   935517
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 17685925
SIC: 2834 Pharmaceutical Preparations